BCIQ Profiles

Company Profile ReportTarget Profile Report
0722 ECP PAQ
BioCentury & Getty Images

Emerging Company Profile

PAQ: small molecules for autophagy-dependent degradation

Emerging Company Profile: PAQ is creating small molecules that promote autophagy-dependent degradation of proteins and non-proteins

PAQ Therapeutics is creating autophagosome-tethering compounds for targeted degradation of proteins and non-proteins via the autophagy pathway.

Jul 22, 2021 | 8:34 PM GMT

With a July 15th $30 million series A round

Read the full 583 word article

How to gain access

Continue reading with a
two-week free trial.